Trial reportDrug design, development and therapy2026
Optimal Interval for Intermittent Epidural Bolus with Ropivacaine-Dexmedetomidine Using the Epidural Dural Puncture Technique for Labour Analgesia: A Coin Bias Up-Down Study.
Trial report in Drug design, development and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to establish the 90% effective interval time for programmed intermittent epidural bolus (PIEB) following dural puncture epidural (DPE) analgesia with a dexmedetomidine ropivacaine combination for primiparas in the first stage of labor. Patients and Methods: This biased coin up and down sequential allocation trial enrolled 40 nulliparous women requesting labor analgesia. After an initial loading dose, analgesia was maintained with PIEB of a fixed volume of 8 mL of the same solution, starting 1 hour later. The initial PIEB interval was set at 60 minutes for the first patient and subsequently adjusted by ± 5 minutes based on the outcome of the previous patient, following the biased-coin design. A successful interval was defined as no requirement for supplemental analgesia. The primary outcome was the 90% effective PIEB interval (ED90) for the first stage of labor. Secondary outcomes included patient satisfaction, the incidence of motor and sensory block, and adverse events. Results: Isotonic regression analysis estimated the 90% effective PIEB interval as 34.5 min (95% confidence interval: 31.0-37.0 min). All patients reported a very high level of satisfaction. The incidence of motor block was 10%, while 37.5% of patients achieved the highest sensory block at the T6 level or above. Notably, no cases of excessive sedation, hypotension, or bradycardia. Conclusion: For DPE labor analgesia using 8 mL of 0.075% ropivacaine combined with 0.4 μg/mL dexmedetomidine, the optimal PIEB interval is approximately 35 min. This interval can reduce breakthrough pain and the need for rescue analgesia. This finding provides a practical, evidence-based reference for optimizing PIEB regimens in clinical labor analgesia, contributing to improved maternal comfort and labor experience while ensuring safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.